Organization
Liaoning Chengda Biotechnology
1 clinical trial
Clinical trial
A Phase Ⅳ, Randomized, Controlled, Open-label, Immunogenicity Study of Vero Cell-derived Inactivated Japanese Encephalitis Vaccine (JEV-I) Co-administered With Measles-Mumps-Rubella Vaccine (MMR)Status: Recruiting, Estimated PCD: 2024-09-30